Clinical Trial Update: Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria [Phase 3]

View source ↗

Summary

This document describes a Phase 3 randomized, double-blind trial comparing APROVEL to placebo in Chinese patients with hypertension and type 2 diabetes with mic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus with Nephropathy

Drugs mentioned

• Aprovel (irbesartan)

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 3 | Status: COMPLETED